Toshifumi Hoki

4PUBLICATIONS
12CO-AUTHORS
Haematological tumoursTumour immunologyPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 25, 2025
Divergent transcriptional states and kinetics of circulating tumor-infiltrating lymphocyte repertoires with highly homologous T-cell receptor sequences in a patient during immunotherapy.

Ryutaro Kajihara, Mark D Long, Toshifumi Hoki

|Jun 17, 2024
Generation, Transcriptomic States, and Clinical Relevance of CX3CR1+ CD8 T Cells in Melanoma.

Hirohito Ishigaki, Takayoshi Yamauchi, Mark D Long

|Mar 04, 2021
T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors.

Takayoshi Yamauchi, Toshifumi Hoki, Takaaki Oba

|Aug 28, 2020
A Critical Role of CD40 and CD70 Signaling in Conventional Type 1 Dendritic Cells in Expansion and Antitumor Efficacy of Adoptively Transferred Tumor-Specific T Cells.

Takaaki Oba, Toshifumi Hoki, Takayoshi Yamauchi

Pageof 1

Frequent Collaborators

4 joint publications

Takayoshi Yamauchi

4 joint publications

Fumito Ito

2 joint publications

Brahm H Segal

2 joint publications

Mark D Long